Literature DB >> 3449313

Thalidomide and cell mediated immunity in Behçet's disease.

M Hamza, K Hamzaoui, K Ayed, M Eleuch, A Zribi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3449313     DOI： 10.1007/BF02330603

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  3 in total

1.  Treatment of Behçet's disease with thalidomide.

Authors:  M H Hamza
Journal:  Clin Rheumatol       Date:  1986-09       Impact factor: 2.980

2.  Functional aberration of T cell subsets in patients with Behçet's disease.

Authors:  T Sakane; H Kotani; S Takada; T Tsunematsu
Journal:  Arthritis Rheum       Date:  1982-11

3.  Cell-mediated immune functions and immunoregulatory cells in Behçet's syndrome.

Authors:  R M Victorino; P Ryan; G R Hughes; H J Hodgson
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330
  3 in total
  1 in total

1.  Treatment of Behçet's disease with dapsone.

Authors:  M Hamza; K Hamzaoui; K Ayed
Journal:  Clin Rheumatol       Date:  1989-03       Impact factor: 2.980
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.